Publication:

Adenosine A1 Receptors Promote Vasa Vasorum Endothelial Cell Barrier Integrity via G(_{i}) and Akt-Dependent Actin Cytoskeleton Remodeling

Loading...
Thumbnail Image

Open/View Files

Date

2013

Journal Title

Journal ISSN

Volume Title

Publisher

Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Siddaramappa Umapathy, Nagavedi, Elzbieta Kaczmarek, Nooreen Fatteh, Nana Burns, Rudolf Lucas, Kurt R. Stenmark, Alexander D. Verin, and Evgenia V. Gerasimovskaya. 2013. Adenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via G\(_{i}\) and Akt-dependent actin cytoskeleton remodeling. PLoS ONE 8(4): e59733.

Abstract

Background: In a neonatal model of hypoxic pulmonary hypertension, a dramatic pulmonary artery adventitial thickening, accumulation of inflammatory cells in the adventitial compartment, and angiogenic expansion of the vasa vasorum microcirculatory network are observed. These pathophysiological responses suggest that rapidly proliferating vasa vasorum endothelial cells (VVEC) may exhibit increased permeability for circulating blood cells and macromolecules. However, the molecular mechanisms underlying these observations remain unexplored. Some reports implicated extracellular adenosine in the regulation of vascular permeability under hypoxic and inflammatory conditions. Thus, we aimed to determine the role of adenosine in barrier regulation of VVEC isolated from the pulmonary arteries of normoxic (VVEC-Co) or chronically hypoxic (VVEC-Hyp) neonatal calves. Principal Findings We demonstrate via a transendothelial electrical resistance measurement that exogenous adenosine significantly enhanced the barrier function in VVEC-Co and, to a lesser extent, in VVEC-Hyp. Our data from a quantitative reverse transcription polymerase chain reaction show that both VVEC-Co and VVEC-Hyp express all four adenosine receptors (A1, A2A, A2B, and A3), with the highest expression level of A1 receptors (A1Rs). However, A1R expression was significantly lower in VVEC-Hyp compared to VVEC-Co. By using an A1R-specific agonist/antagonist and siRNA, we demonstrate that A1Rs are mostly responsible for adenosine-induced enhancement in barrier function. Adenosine-induced barrier integrity enhancement was attenuated by pretreatment of VVEC with pertussis toxin and GSK690693 or LY294002, suggesting the involvement of G({i}) proteins and the PI3K-Akt pathway. Moreover, we reveal a critical role of actin cytoskeleton in VVEC barrier regulation by using specific inhibitors of actin and microtubule polymerization. Further, we show that adenosine pretreatment blocked the tumor necrosis factor alpha (TNF-α)-induced permeability in VVEC-Co, validating its anti-inflammatory effects. Conclusions: We demonstrate for the first time that stimulation of A1Rs enhances the barrier function in VVEC by activation of the G({i})/PI3K/Akt pathway and remodeling of actin microfilament.

Description

Research Data

Keywords

Biology, Molecular Cell Biology, Signal Transduction, Signaling Cascades, Akt Signaling Cascade, Medicine, Cardiovascular, Acute Cardiovascular Problems, Cardiovascular Pharmacology, Hypertension, Pulmonary Vascular Diseases, Stroke, Valvular Disease, Vascular Biology, Critical Care and Emergency Medicine, Pediatric Critical Care, Respiratory Failure, Sepsis, Pulmonology, Pediatric Pulmonology

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories